Firms focused on drug discovery, genetic research, and life sciences.
Theme Performance
Equal-weight basket of constituents
1 Day
-0.52%
1 Week
+0.31%
1 Month
-6.66%
3 Months
+5.44%
Year to Date
+4.08%
Constituents
15 active symbols
| Ticker | Company | Market Cap | Price | 1D % | 1W % | 1M % | 3M % | YTD % |
|---|---|---|---|---|---|---|---|---|
| Amgen Inc | $187.563B | $342.5700 | -1.51% | -1.48% | -8.26% | +6.30% | +6.20% | |
| Gilead Sciences Inc | $173.409B | $140.1300 | -0.42% | +2.07% | -5.74% | +13.83% | +14.89% | |
| Vertex Pharmaceuticals Inc | $111.447B | $434.3000 | -1.91% | -3.31% | -8.20% | -3.23% | -2.97% | |
| Regeneron Pharmaceuticals Inc | $78.943B | $763.0400 | -1.98% | +0.68% | -3.26% | -1.30% | -1.86% | |
|
A
ARGX
|
argenx SE American Depositary Shares | $46.325B | $748.2500 | +0.44% | +7.73% | -0.42% | -11.24% | -11.14% |
| Alnylam Pharmaceuticals, Inc. | $42.287B | $330.3400 | -3.01% | -2.84% | -2.58% | -19.82% | -20.32% | |
| Biogen Inc. Common Stock | $26.026B | $172.3400 | -3.50% | -7.18% | -6.63% | +0.77% | -0.27% | |
|
B
BNTX
|
BioNTech SE American Depositary Share | $22.916B | $91.2800 | +1.97% | +4.25% | -12.16% | -4.22% | -5.70% |
| Illumina Inc | $19.476B | $127.7400 | +0.59% | +2.40% | -1.23% | -2.88% | -5.19% | |
| Incyte Genomics Inc | $19.091B | $94.8600 | +1.73% | +3.98% | -2.96% | -2.88% | -5.41% | |
| Moderna, Inc. Common Stock | $17.700B | $48.7700 | -1.66% | -8.16% | -14.88% | +66.84% | +59.43% | |
| Jazz Pharmaceuticals, Inc. | $9.995B | $186.8500 | -0.70% | -1.16% | -0.92% | +9.97% | +7.97% | |
| CRISPR Therapeutics AG | $4.752B | $49.1500 | +1.43% | +4.12% | -17.48% | -5.59% | -7.92% | |
| Beam Therapeutics Inc. Common Stock | $2.512B | $24.2300 | +1.82% | +4.40% | -10.13% | -11.04% | -9.14% | |
| Intellia Therapeutics, Inc | $1.551B | $13.3000 | -1.06% | -0.83% | -4.99% | +46.05% | +42.56% |
